TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
FTRE

Fortrea Holdings Inc.

Healthcare · Biotechnology

20.00$ +2.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet FTRE
Line item 2020 2021 2022 2023 2024 2025
– 100.0% 100.0% 100.0% 100.0% 100.0%
– 25.6% 29.1% 28.9% 26.5% 33.0%
– 2.2% 2.6% 2.5% 3.3% 6.4%
– 2.2% 2.6% 2.5% 3.3% 6.4%
– 21.7% 24.5% 23.3% 19.4% 22.8%
– – – 0.8% – –
– 47.6% 46.6% 40.1% 47.8% 35.4%
– 21.4% 19.2% 16.8% 18.3% 22.9%
– 25.4% 22.0% 60.4% 61.9% 79.3%
– 18.9% 16.3% 18.0% 26.5% 33.6%
– 0.5% 0.5% 1.0% 2.5% 0.5%
– 1.4% 1.9% 3.1% 3.9% 1.1%
– – – 36.1% 29.3% 38.6%
– 74.6% 78.0% 39.6% 38.1% 20.7%
– -3.4% -6.4% -1.6% -11.1% -50.9%
– 2.0% 2.1% 2.0% 2.5% 3.4%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?